ACB Stock Overview
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Aurora Cannabis Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$9.01 |
| 52 Week High | CA$15.50 |
| 52 Week Low | CA$3.84 |
| Beta | 2.93 |
| 1 Month Change | 82.39% |
| 3 Month Change | 63.82% |
| 1 Year Change | 9.88% |
| 3 Year Change | -90.99% |
| 5 Year Change | -99.39% |
| Change since IPO | -83.31% |
Recent News & Updates
Recent updates
Why Aurora Cannabis' (TSE:ACB) Earnings Are Weaker Than They Seem
Feb 15
Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Sep 12Investors Holding Back On Aurora Cannabis Inc. (TSE:ACB)
Jun 13Is Aurora Cannabis (TSE:ACB) Using Debt Sensibly?
Jan 15Downgrade: Here's How Analysts See Aurora Cannabis Inc. (TSE:ACB) Performing In The Near Term
Nov 13Does Aurora Cannabis (TSE:ACB) Have A Healthy Balance Sheet?
Sep 22Aurora Cannabis (TSE:ACB) Is Carrying A Fair Bit Of Debt
Apr 21Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Jan 05A Look At The Intrinsic Value Of Aurora Cannabis Inc. (TSE:ACB)
Nov 13Is Aurora Cannabis (TSE:ACB) Weighed On By Its Debt Load?
Oct 04Aurora Cannabis Inc. (TSE:ACB) Shares Could Be 46% Below Their Intrinsic Value Estimate
Aug 10Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Jul 06Analysts Have Just Cut Their Aurora Cannabis Inc. (TSE:ACB) Revenue Estimates By 19%
May 15Shareholder Returns
| ACB | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -4.1% | -4.9% | -1.9% |
| 1Y | 9.9% | 55.7% | 3.7% |
Return vs Industry: ACB underperformed the Canadian Pharmaceuticals industry which returned 55.7% over the past year.
Return vs Market: ACB exceeded the Canadian Market which returned 3.7% over the past year.
Price Volatility
| ACB volatility | |
|---|---|
| ACB Average Weekly Movement | 19.4% |
| Pharmaceuticals Industry Average Movement | 14.1% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: ACB's share price has been volatile over the past 3 months.
Volatility Over Time: ACB's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,130 | Miguel Martin | www.auroramj.com |
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Aurora Cannabis Inc. Fundamentals Summary
| ACB fundamental statistics | |
|---|---|
| Market cap | CA$491.40m |
| Earnings (TTM) | CA$410.72m |
| Revenue (TTM) | CA$275.88m |
1.2x
P/E Ratio1.8x
P/S RatioIs ACB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACB income statement (TTM) | |
|---|---|
| Revenue | CA$275.88m |
| Cost of Revenue | CA$190.60m |
| Gross Profit | CA$85.29m |
| Other Expenses | -CA$325.43m |
| Earnings | CA$410.72m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.53 |
| Gross Margin | 30.91% |
| Net Profit Margin | 148.87% |
| Debt/Equity Ratio | 9.8% |
How did ACB perform over the long term?
See historical performance and comparison